Sunshine Act Meeting Notice, 65544 [06-9160]

Download as PDF cprice-sewell on PRODPC62 with NOTICES 65544 Federal Register / Vol. 71, No. 216 / Wednesday, November 8, 2006 / Notices Public Hearing: A public hearing in connection with this first investigation and report will be held at the U.S. International Trade Commission Building, 500 E Street, SW., Washington, DC beginning at 9:30 a.m. on March 8, 2007. Requests to appear at the public hearing should be filed with the Secretary, no later than 5:15 p.m., February 22, 2007, in accordance with the requirements in the ‘‘Submissions’’ section below. Written Submissions: In lieu of or in addition to participating in the hearing, interested parties are invited to submit written statements or briefs concerning this investigation. All written submissions, including requests to appear at the hearing, statements, and briefs, should be addressed to the Secretary, United States International Trade Commission, 500 E Street, SW., Washington, DC 20436. Any pre-hearing briefs or statements should be filed not later than 5:15 p.m., February 22, 2007; the deadline for filing post-hearing briefs or statements is 5:15 p.m., March 22, 2007. All written submissions must conform with the provisions of section 201.8 of the Commission’s Rules of Practice and Procedure (19 CFR 201.8). Section 201.8 requires that a signed original (or a copy so designated) and fourteen (14) copies of each document be filed. In the event that confidential treatment of a document is requested, at least four (4) additional copies must be filed, in which the confidential information must be deleted (see the following paragraph for further information regarding confidential business information). The Commission’s rules do not authorize filing submissions with the Secretary by facsimile or electronic means, except to the extent permitted by rule section 201.8 (19 CFR 201.8) (see Handbook for Electronic Filing Procedures, ftp:// ftp.usitc.gov/pub/reports/ electronic_filing_handbook.pdf). Persons with questions regarding electronic filing should contact the Secretary (202–205–2000 or edis@usitc.gov). Any submissions that contain confidential business information must also conform with the requirements of section 201.6 of the Commission’s Rules of Practice and Procedure (19 CFR 201.6). Section 201.6 of the rules require that the cover of the document and the individual pages be clearly marked as to whether they are the ‘‘confidential’’ or ‘‘non-confidential’’ version, and that the confidential business information be clearly identified by means of brackets. All written submissions, except for confidential business information, will VerDate Aug<31>2005 15:11 Nov 07, 2006 Jkt 211001 be made available for inspection by interested parties. In its request letter, the Committee stated that it intends to make the Commission’s report available to the public in its entirety, and asked that the Commission not include any confidential business information or national security classified information in the reports that the Commission sends to the Committee. Any confidential business information received by the Commission in this investigation and used in preparing this report will not be published in a manner that would reveal the operations of the firm supplying the information. General information concerning the Commission may also be obtained at http://www.usitc.gov. The public record for this investigation may be viewed on the Commission’s electronic docket (EDIS) at http://www.usitc.gov/ secretary/edis.htm. Hearing-impaired individuals are advised that information on this matter can be obtained by contacting our TDD terminal on (202) 205–1810. Persons with mobility impairments who will need special assistance in gaining access to the Commission should contact the Office of the Secretary at 202–205–2000. Issued: November 2, 2006. By order of the Commission. Marilyn R. Abbott, Secretary to the Commission. [FR Doc. E6–18846 Filed 11–7–06; 8:45 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application Pursuant to § 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on August 21, 2006 and August 24, 2006, Johnson Matthey, Inc., Custom Pharmaceuticals Department, 2003 Nolte Drive, West Deptford, New Jersey 08066, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule II: Drug Schedule Nabilone (7379) ............................ Noroxymorphone (9668) .............. II II The company plans to manufacture the listed controlled substances in bulk for sales to its customers. PO 00000 Frm 00094 Fmt 4703 Sfmt 4703 Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections being sent via regular mail should be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537, Attention: DEA Federal Register Representative/ODL; or any being sent via express mail should be sent to DEA Headquarters, Attention: DEA Federal Register Representative/ ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must be filed no later than January 8, 2007. Dated: November 2, 2006. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E6–18844 Filed 11–7–06; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Foreign Claims Settlement Commission [F.C.S.C. Meeting Notice No. 9–06] Sunshine Act Meeting Notice The Foreign Claims Settlement Commission, pursuant to its regulations (45 CFR Part 504) and the Government in the Sunshine Act (5 U.S.C. 552b), hereby gives notice in regard to the scheduling of meetings for the transaction of Commission business and other matters specified, as follows: Thursday, November 16, 2006, at 10 a.m. DATE AND TIME: SUBJECT MATTER: Issuance of Amended Proposed Decisions and Amended Final Decisions in claims against Albania. Open. All meetings are held at the Foreign claims Settlement Commission, 600 E Street, NW., Washington, DC. Requests for information, or advance notices of intention to observe an open meeting, may be directed to: Administrative Officer, Foreign Claims Settlement Commission, 600 E Street, NW., Room 6002, Washington, DC 20579. Telephone: (202) 616–6988. STATUS: Mauricio J. Tamargo, Chairman. [FR Doc. 06–9160 Filed 11–6–06; 3:48 pm] BILLING CODE 4410–01–P E:\FR\FM\08NON1.SGM 08NON1

Agencies

[Federal Register Volume 71, Number 216 (Wednesday, November 8, 2006)]
[Notices]
[Page 65544]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-9160]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Foreign Claims Settlement Commission

[F.C.S.C. Meeting Notice No. 9-06]


Sunshine Act Meeting Notice

    The Foreign Claims Settlement Commission, pursuant to its 
regulations (45 CFR Part 504) and the Government in the Sunshine Act (5 
U.S.C. 552b), hereby gives notice in regard to the scheduling of 
meetings for the transaction of Commission business and other matters 
specified, as follows:

Date and Time: Thursday, November 16, 2006, at 10 a.m.

Subject Matter: Issuance of Amended Proposed Decisions and Amended 
Final Decisions in claims against Albania.

Status: Open.
    All meetings are held at the Foreign claims Settlement Commission, 
600 E Street, NW., Washington, DC. Requests for information, or advance 
notices of intention to observe an open meeting, may be directed to: 
Administrative Officer, Foreign Claims Settlement Commission, 600 E 
Street, NW., Room 6002, Washington, DC 20579. Telephone: (202) 616-
6988.

Mauricio J. Tamargo,
Chairman.
[FR Doc. 06-9160 Filed 11-6-06; 3:48 pm]
BILLING CODE 4410-01-P